FDA Brief

Warning letters Drugs

FDA warning letter to

Exela Pharma Sciences LLC

Issued Apr 8, 2021Posted Apr 27, 2021Office of Pharmaceutical Quality Operations, Division II

Unapproved New Drug/Compounding/Misbranding. We haven't summarized this letter yet. Read it on fda.gov.

Exela Pharma Sciences LLC's FDA history

  1. Exela Pharma Sciences, LLC

    CGMP/Finished Pharmaceuticals/Adulterated

Full company page